IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 180 filers reported holding IMPAX LABORATORIES INC in Q1 2014. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,484,000 | -87.9% | 73,100 | -92.5% | 0.01% | -89.8% |
| Q1 2017 | $12,276,000 | -4.3% | 970,400 | +223.5% | 0.13% | -60.7% |
| Q4 2015 | $12,828,000 | +35.0% | 300,000 | 0.0% | 0.33% | +101.2% |
| Q4 2014 | $9,504,000 | +167.2% | 300,000 | +100.0% | 0.16% | +153.1% |
| Q3 2014 | $3,557,000 | -76.3% | 150,000 | -70.0% | 0.06% | -66.0% |
| Q2 2014 | $14,995,000 | +62.2% | 500,000 | +42.9% | 0.19% | +27.9% |
| Q1 2014 | $9,247,000 | +85.5% | 350,000 | +40.0% | 0.15% | +70.9% |
| Q2 2013 | $4,985,000 | – | 250,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
| Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
| BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
| Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
| Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
| Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
| Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
| Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |